FIELD: medicine.
SUBSTANCE: invention refers to medicine, namely to oncology, and can be used for pain syndromes reduction caused by malignant new growths. That is ensured by xenotherapy in normobaric conditions by closed breathing circuit with the help of gas analyzer with gas mix of xenon and oxygen 50/50 vol. %, amount of mixture from 4 to 6 l in courses of 5 to 10 days for 1-2 procedures, each from 05 to 15 min a day with intervals between procedures of 4–6 hours.
EFFECT: method enables rapid and effective reduction of pain syndrome and neuropathic component of pain with reduction of dose and number of analgesics taken, improvement of patient's life quality and absence of side effects.
1 cl, 4 ex
| Title | Year | Author | Number |
|---|---|---|---|
| METHOD OF TREATING PAIN IN REHABILITATION OF ONCOLOGICAL PATIENTS AFTER PERFORMING SPINAL SURGICAL INTERVENTIONS | 2019 |
|
RU2713455C2 |
| METHOD OF REDUCTION OF THE EXPRESSION OF CHRONIC PAIN SYNDROME IN PATIENTS WITH PANCREATIC CANCER WITH FUNCTIONAL STATUS ECOG 0-2 POINTS | 2022 |
|
RU2793519C2 |
| METHOD OF TREATMENT OF CHRONIC POSTHERPETIC NEURALGIA | 2022 |
|
RU2802669C1 |
| METHOD OF POSTOPERATIVE PAIN RELIEF WHEN PERFORMING DECOMPRESSION AND STABILIZING OPERATIONS ON SPINE IN CANCER PATIENTS WITH CHRONIC PAIN SYNDROME | 2023 |
|
RU2811265C2 |
| METHOD OF TREATING CHRONIC PAIN | 2019 |
|
RU2726048C1 |
| METHOD OF POSTOPERATIVE PAIN RELIEF FOR CANCER PATIENTS WITH CHRONIC PAIN SYNDROME WHEN PERFORMING DECOMPRESSIVE AND STABILIZING OPERATIONS ON SPINE | 2023 |
|
RU2811259C2 |
| ANALGESIC AGENT AND THERAPY OF PAIN SYNDROME OF VARIOUS AETIOLOGIES BY USING SAID AGENT | 2007 |
|
RU2367432C2 |
| METHOD FOR TREATING METASTATIC CEREBRAL AFFECTION | 2015 |
|
RU2599195C1 |
| METHOD OF TREATING SENSITIVITY IMPAIRMENT IN CASE OF GUILLAIN BARRE SYNDROME | 2012 |
|
RU2477114C1 |
| METHOD OF TREATING ONCOLOGICAL PAIN | 2019 |
|
RU2707954C1 |
